Trailhead Biosystems Raises $10 Million To Accelerate Growth
10/11/22, 12:31 PM
Location
clevelandMoney raised
$10 million
Industry
biotechnology
Trailhead Biosystems Inc. (www.trailbio.com) - a biotechnology company pioneering the application of machine-enabled science towards understanding and controlling biology - announced completion of a $10 million Series A-2 equity financing. The company has developed revolutionary platform for generating specialized human cells for use in therapeutic cell development, drug discovery, organ-on-a-chip development, 3D organ printing, and human disease modeling.
Company Info
Location
cleveland, ohio, united states
Additional Info
Trailhead Biosystems is pioneering the development of cell-based therapeutics using machine learning and bioinformatics. Trailhead's proprietary HD-DoETM platform merges developmental biology and cell therapeutics with advanced robotics, computerized experimental design, and analysis to perform process-specific parameter optimization in the development of cell therapies.